Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Vertex Pharmaceuticals Inc Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $83.4 Billion
- Q1 2025
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 960,854 shares of VRTX stock, worth $424 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
960,854
Previous 970,662
1.01%
Holding current value
$424 Million
Previous $391 Million
19.18%
% of portfolio
0.56%
Previous 0.43%
Shares
33 transactions
Others Institutions Holding VRTX
# of Institutions
1,834Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.6 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.41 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.41 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.2 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $113B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...